Association of tumor necrosis factor alpha, interferon gamma and interleukin 10 gene polymorphisms with peripheral neuropathy in South Indian patients with type 2 diabetes

Cytokine

Volumn 47, Issue 3, 2009, Pages 173-177

  Kolla, Venkata Karunakar ^a,b   Madhavi, G ^a   Pulla Reddy, B ^a   Srikanth Babu, B M V ^a   Yashovanthi, J ^a   Valluri, Vijaya Lakshmi ^b   Ramesh, Jayanthy ^c   Akka, Jyothy ^a  

^a OSMANIA UNIVERSITY   (India)

^b LEPRA Society   (India)

^c OSMANIA GENERAL HOSPITAL   (India)

Author keywords

Cytokine; Diabetic peripheral neuropathy; Interferon gamma; Interleukin 10; Tumor necrosis factor alpha

Indexed keywords

ADENINE; GAMMA INTERFERON; GUANINE; INTERLEUKIN 10; THYMINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DOWN REGULATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MARKER; GENOTYPE; HUMAN; IMMUNOREGULATION; INDIAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; INDIA; INTERFERON-GAMMA; INTERLEUKIN-10; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 68949155372     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.06.007     Document Type: Article

References (44)

1. Watkins P.J. Natural History of the Diabetic Neuropathies. QJM 77 (1990) 1209-1218
2. Dyck P.J., Kratz K.M., Karnes J.L., Litchy W.J., Klein R., and Pach J.M. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a populationbased cohort: the rochester diabetic neuropathy study. Neurology 43 (1993) 817-824
3. Miesse A.M., Willey J.S., and Bateman T.A. Potential role of proinflammatory cytokines in nerve damage related bone loss. Biomed Sci Instrum 40 (2004) 266-271
4. Manandhar R., Shrestha N., Butlin C.R., and Roche P.W. High levels of inflammatory cytokines are associated with poor clinical response to steroid treatment and recurrent episodes of type 1 reactions in leprosy. Clin Exp Immunol 128 (2002) 333-338
5. Hutchinson I.V., Turner D.M., Sankaran D., Awad M.R., and Sinnott P.J. Influence of cytokine genotypes on allograft rejection. Transplant Proc 30 (1998) 862-863
6. Hutchinson, Pravica V., Hajeer A., and Sinnott P.J. Identification of high and low responders to allografts. Rev mmunogent 1 (1999) 323-333
7. Sankaran D., Asderakis A., Ashraf S., Roberts I.S., Dyer P.A., et al. Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. Kidney Int 56 (1999) 281-288
8. Nagatsu T., Mogi M., Ichinose H., and Togari A. Cytokines in Parkinson's disease. J Neural Trans Suppl 58 (2000) 143-151
9. Hans-Peter M.D. Immune-mediated demyelination Hartung. Annal Neurol 33 (2004) 563-567
10. Koski, and Lee C. Mechanisms of schwann cell damage in inflammatory neuropathy. J Infect Dis 176 S2 (1997) 169-172
11. Jo S., Yagihashi S., and Toyota T. The possible role of tumor necrosis factor alpha in diabetic neuropathy. Experimental Diab Res 4 (2003) 65-71
12. Santos A.R., Almeida A.S., and Suffys P.N. Tumor necrosis factor promoter polymorphism (TNF2) seemed to protect against development of severe forms of leprosy in a pilot study in Brazilian patients. Int J Lepr Other Mycobact Dis 68 (2000) 325-327
13. McGuire W., Hill A.V.S., Allsopp C.E.M., Greenwood B.M., and Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 371 (1994) 508-511
14. Cabrera M., Shaw M.A., Sharpes C., Williams H., Castes M., and Blackwell C.J. Polymorphism in Tumor Necrosis Factor Genes Associated with Mucocutaneous Leishmaniasis. J. M. J Exp Med 182 (1995) 1259-1264
15. Billiau A., Heremans H., Vermeire K., and Matthys P. Immunomodulatory properties of interferon-gamma. Ann NY Acad Sci 856 (1998) 22-32
16. Govan V.A., Carrara H.R.O., Sachs J.A., Hoffman M., Stanczuk G.A., and Williamson A.-L. Ethnic differences in allelic distribution of IFN-gamma in South African women but no link with cervical cancer. J Carcinogen 2 (2003) 1-8
17. Pravica V., Perrey C., Stevens A., Lee J.H., and Hutchinson I.V. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 61 (2000) 863-866
18. Yssel H., De Waal Malefyt R., Roncarolo M.G., Abrams J.S., Lahesmaa R., Spits H., et al. IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J Immunol 149 (1992) 2378-2384
19. Moore K.W., de Waal Malefyt R., Coffman R.L., and O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19 (2001) 683
20. Turner D.M., Williams D.M., Sankaran D., Lazarus M., Sinnott P.J., and Hutchinson I.V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogent 24 (1997) 1-8
21. Young M.J., Boulton A.J.M., Macleod A.F., Williams D.R.R., and Sonksen P.H. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 36 (1993) 150-154
22. Louis R., Leyder E., Malaise M., Bartsch P., and Louis E. Lack of association between adult asthma and the tumour necrosis factor alpha - 308 polymorphism gene. Eur Respir J 16 (2000) 604-608
23. Perrey C., Turner S.J., Pravica V., Howell W.M., and Hutchinson I.V. ARMS-PCR methodologies to determine IL-10, TNF-alpha, TNF-beta and TGF-beta1 gene polymorphisms. Transpl Immunol 7 (1999) 127-128
24. Dolores L.-M., Arnalich F., Serantes R., Gonzalez A., Codoceo R., Madero R., et al. Interferon-gamma and Interleukin-10 gene polymorphisms in pulmonary tuberculosis. Am J Respir Crit Care Med 167 (2003) 970-975
25. Sarno E.N., Santos A.R., Jardim M.R., Suffys P.N., Almeida A.S., Nery J.A., et al. Pathogenesis of nerve damage in leprosy: genetic polymorphism regulates the production of TNF alpha. Lepr Rev 71 (2000) S154-S158
26. Santos A.R., Suffys P.N., Vanderborght P.R., Moraes M.O., Vieira L.M., Cabello P.H., et al. Role of tumor necrosis factor-alpha and interleukin-10 promoter gene polymorphisms in leprosy. J Infect Dis 186 (2002) 1687-1691
27. Selmaj M.R., and Raine C.S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23 (1988) 339
28. Brosman C.F., Selmag K., and Raine C.S. Hypothesis: a role for tumor necrosis factor in immune mediated demyelination and its relevance to multiple sclerosis. J Neuroimmunol 18 (1988) 87
29. Nilsson J., Jovinge S., Niemann A., Reneland R., and Lithell H. Relation between plasma tumor necrosis factor-alpha and insulin sensitivity in elderly men with non insulin dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 18 (1998) 1286-1292
30. Kroeger K.M., Carville K.S., and Abraham L.J. The -308 tumor necrosis factor alpha promoter polymorphism effects transcription. Mol Immunol 34 (1997) 391-399
31. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., and Duff G.W. Effects of a polymorphism in hte human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 94 (1997) 3195-3199
32. Mascher B., Schmitt W., Csernok E., Tatsis E., Reil A., and Gross W.L. Polymorphisms in the tumor necrosis factor genes in Wegener's granulomatosis. Exp Clin Immunogenet 14 (1997) 226-233
33. Gencik M., Borgmann S., Zahn R., Albert E., Sitter T., and Epplen J.T. Immunogenetic risk factors for anti-netrophil cytoplasmic antibody (ANCA) associated systemic vasculitis. Clin Exp Immunol 117 (1999) 412-417
34. Shiau M.Y., Wu C.Y., Huang C.N., Hu S.-W., Lin S.J., and Chang Y.H. TNF-polymorphisms and type 2 diabetes mellitus in Taiwanese patients. Tissue Antigens 61 (2003) 393-397
35. Rengarajan J., Szabo S.J., and Glimcher L.H. Transcriptional regulation of Th1/Th2 polarization. Immunol Today 21 (2000) 479-483
36. Heinemeyer T., Wingender E., Reuter I., Hermjakob H., Kel A.E., Kel O.V., et al. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 26 (1998) 362-367
37. Kordi Tamandani M.K., Sobti R.C., Shekari M., Mukesh M., and Suri V. Expression and polimorphism of IFN-gamma gene in patients with cervical cancer. Exp Oncol 30 (2008) 224-229
38. Settin A., Abdel-Hady H., El-Baz R., and Saber I. Gene polymorphisms of TNF-alpha(-308), IL-10(-1082), IL-6(-174), and IL-1Ra(VNTR) related to susceptibility and severity of rheumatic heart disease. Pediatr Cardiol 28 (2007) 363-371
39. Girndt M., Ulrich C., Kaul H., Sester U., Sester M., and Kohler H. Uremia-associated immune defect: the IL-10-CRP axis. Kidney Int Suppl 84 (2003) S76-S79
40. Tagore A., Gonsalkorale W.M., Pravica V., et al. Interleukin-10 (IL-10) genotypes in inflammatory bowel disease. Tissue Antigens 54 (1999) 386-390
41. Fen Wu, Yabin Qu, Yunxia Tang, Duozhi Cao, Pin Sun, Zhaolin Xia. Lack of Association between Cytokine gene polymorphisms and Silicosis and Pulmonary Tuberculosis in Chinese Iron Miners. J Occup Health 2008;50:445-54.
42. Mukaddes Colakogullari, Engin Ulukaya, Arzu Yilmaztepe Oral, Figen Aymak, Bilkay Basturk, Ahmet Ursavas, et al. The involvement of IL-10, IL-6, IFN-γ, TNF-α and TGF-β gene polymorphisms among Turkish lung cancer patients. Cell Biochem Funct 2008;26:283-90.
43. Marieke E., Veenhoven R.H., Wiertsema S.P., Houwing-Duistermaat J.J., Walraven V., de Groot R., et al. Genetic Polymorphisms in Immunoresponse Genes TNFA, IL6, IL10, and TLR4 Are Associated With Recurrent Acute Otitis Media. Pediatrics 120 (2007) 814-823
44. Hohaus S., Giachelia M., Di Febo A., Martini M., Massini G., Vannata B., et al. Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma. Annal Oncol 18 (2007) 1376-1381